[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Rohto Pharmaceutical Co., Ltd.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100607719","phase-2-exploratory-study-of-adr-002k-for-heart-failure-patients-with-ischemic-heart-disease-who-undergo-cabg-100607719",false,"NCT07192211","Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG","Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo Coronary Artery Bypass Surgery","Inclusion Criteria:\n\n1. Patients clinically diagnosed with chronic heart failure due to ischemic heart disease who undergo CABG\n2. Patients with an LVEF of less than 40% as determined by the cardiac ultrasound at the screening examination.\n3. Others\n\nExclusion Criteria:\n\n1. Patients who have a combination of cardiovascular disease such as severe organic valvular disease.\n2. Patients who have developed acute coronary syndrome within 3 months prior to obtaining consent.\n3. Others","ALL","18 Years","80 Years",{"count":20,"type":21},50,"ESTIMATED","INTERVENTIONAL",[24],"PHASE2","ADR-002K is administered to heart failure patients with ischemic heart disease who undergo coronary artery bypass surgery (CABG) to investigate its efficacy and safety.",[27],"Ischemic Heart Disease","RECRUITING","2026-06-07",{"date":31,"type":32},"2026-06-09","ACTUAL",{"date":34,"type":32},"2026-04-28",{"date":36,"type":21},"2029-03-31",{"name":38,"class":39},"Rohto Pharmaceutical Co., Ltd.","INDUSTRY",""]